Lincoln PharmaceuticalsLINCOLN 
$9.200.04%24h
0.04%24h
Global rank17829
Market cap$184.32M
Change 7d-0.64%
YTD Performance23.32%
SP500 benchmarkOutperform
P/E0.25
P/S3.03
Revenue$60.84M
Earnings$8.69M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Lincoln Pharmaceuticals (LINCOLN)
Lincoln Pharmaceuticals has an EPS of $36.4. In 2022, the company made an earnings per share (EPS) of $34.63. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for LINCOLN
-
Value:-
EPS history for Lincoln Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $36.40 | 5.11% |
| 2022 | $34.63 | 11.42% |
| 2021 | $31.08 | 20.84% |
| 2020 | $25.72 | - |
View the highest EPS stocks
